Real-time enrollment status for this b acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); bcr-abl1 clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:07 PM UTC
| NCT Number | NCT07040982 |
| Recruiting Status | Recruiting |
| Condition | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | June 18, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT07040982 is currently recruiting participants. This clinical trial study for b acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); bcr-abl1 is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07040982 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07040982 was last updated 3 weeks ago (June 18, 2026). HelloStudys verifies this status automatically.